These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28652421)

  • 21. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer.
    Sasako M; Sakuramoto S; Katai H; Kinoshita T; Furukawa H; Yamaguchi T; Nashimoto A; Fujii M; Nakajima T; Ohashi Y
    J Clin Oncol; 2011 Nov; 29(33):4387-93. PubMed ID: 22010012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients.
    Saito M; Kiyozaki H; Takata O; Suzuki K; Rikiyama T
    World J Surg Oncol; 2014 Dec; 12():406. PubMed ID: 25551581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of INHBA expression in human colorectal cancer.
    Okano M; Yamamoto H; Ohkuma H; Kano Y; Kim H; Nishikawa S; Konno M; Kawamoto K; Haraguchi N; Takemasa I; Mizushima T; Ikeda M; Yokobori T; Mimori K; Sekimoto M; Doki Y; Mori M; Ishii H
    Oncol Rep; 2013 Dec; 30(6):2903-8. PubMed ID: 24085226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current status of adjuvant chemotherapy in patients with p-Stage II and p-Stage III gastric cancer].
    Sato Y; Yajima K; Kosugi S; Muneoka Y; Ichikawa H; Hanyu T; Sakamoto K; Ishikawa T; Wakai T
    Gan To Kagaku Ryoho; 2014 Aug; 41(8):961-4. PubMed ID: 25132026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer.
    Takahari D; Hamaguchi T; Yoshimura K; Katai H; Ito S; Fuse N; Kinoshita T; Yasui H; Terashima M; Goto M; Tanigawa N; Shirao K; Sano T; Sasako M
    Cancer Chemother Pharmacol; 2011 Jun; 67(6):1423-8. PubMed ID: 20809123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. INHBA gene silencing inhibits gastric cancer cell migration and invasion by impeding activation of the TGF-β signaling pathway.
    Chen ZL; Qin L; Peng XB; Hu Y; Liu B
    J Cell Physiol; 2019 Aug; 234(10):18065-18074. PubMed ID: 30963572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Relevance of Postoperative Neutrophil-Lymphocyte Ratio (NLR) to Recurrence After Adjuvant Chemotherapy of S-1 for Gastric Cancer.
    Tanaka H; Tamura T; Toyokawa T; Muguruma K; Miki Y; Kubo N; Sakurai K; Hirakawa K; Ohira M
    Anticancer Res; 2018 Jun; 38(6):3745-3751. PubMed ID: 29848737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response Predictors of S-1, Cisplatin, and Docetaxel Combination Chemotherapy for Metastatic Gastric Cancer: Microarray Analysis of Whole Human Genes.
    Kitamura S; Tanahashi T; Aoyagi E; Nakagawa T; Okamoto K; Kimura T; Miyamoto H; Mitsui Y; Rokutan K; Muguruma N; Takayama T
    Oncology; 2017; 93(2):127-135. PubMed ID: 28511180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delay in initiation of postoperative adjuvant chemotherapy with S-1 monotherapy and prognosis for gastric cancer patients: analysis of a multi-institutional dataset.
    Nakanishi K; Kanda M; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Tanaka C; Kobayashi D; Fujiwara M; Murotani K; Kodera Y
    Gastric Cancer; 2019 Nov; 22(6):1215-1225. PubMed ID: 30955110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors predictive of recurrence after surgery for gastric cancer followed by adjuvant S-1 chemotherapy.
    Wada T; Kunisaki C; Hasegawa S; Takagawa R; Momiyama M; Kosaka T; Makino H; Ono HA; Oshima T; Akiyama H; Endo I
    Anticancer Res; 2013 Apr; 33(4):1747-51. PubMed ID: 23564827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer.
    Fukuchi M; Ishiguro T; Ogata K; Suzuki O; Kumagai Y; Ishibashi K; Ishida H; Kuwano H; Mochiki E
    Ann Surg Oncol; 2015 Oct; 22(11):3618-24. PubMed ID: 25663597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of prognostic factors for the response to S-1 in patients with stage II or III advanced gastric cancer who underwent gastrectomy.
    Ishido K; Azuma M; Koizumi W; Takeuchi A; Sakuramoto S; Watanabe M; Okayasu I
    Pharmacogenet Genomics; 2009 Dec; 19(12):955-64. PubMed ID: 19898266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the
    Kano K; Sakamaki K; Oue N; Kimura Y; Hashimoto I; Hara K; Maezawa Y; Aoyama T; Fujikawa H; Hiroshima Y; Yamada T; Tamagawa H; Yamamoto N; Ogata T; Cho H; Ito H; Shiozawa M; Yukawa N; Yoshikawa T; Morinaga S; Rino Y; Yasui W; Masuda M; Miyagi Y; Oshima T
    In Vivo; 2020; 34(1):461-467. PubMed ID: 31882514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved Efficacy by Addition of Protein-bound Polysaccharide K to Adjuvant Chemotherapy for Advanced Gastric Cancer.
    Fukuchi M; Mochiki E; Ishiguro T; Ogura T; Sobajima J; Kumagai Y; Ishibashi K; Ishida H
    Anticancer Res; 2016 Aug; 36(8):4237-41. PubMed ID: 27466538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postoperative adjuvant chemotherapy with S-1 alters recurrence patterns and prognostic factors among patients with stage II/III gastric cancer: A propensity score matching analysis.
    Kanda M; Murotani K; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Surgery; 2015 Dec; 158(6):1573-80. PubMed ID: 26120068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical Impact of adjuvant chemotherapy in patients with T1N2/3 Gastric cancer].
    Tsuchida K; Kunisaki C; Watanabe T; Ono H; Oshima T; Fukushima T; Yoshikawa T; Rino Y; Imada T; Masuda M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2239-41. PubMed ID: 25731482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy.
    Tamura S; Fujitani K; Kimura Y; Tsuji T; Matsuyama J; Iijima S; Imamura H; Inoue K; Kobayashi K; Kurokawa Y; Furukawa H;
    Oncology; 2011; 80(5-6):296-300. PubMed ID: 21778769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy].
    Sakurai Y; Kamoshida S; Furuta S; Sunagawa R; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1147-55. PubMed ID: 18633253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Alternate-day oral therapy with S-1 for adjuvant chemotherapy of gastric cancer].
    Takebayashi K; Kawai Y; Tagi T; Matsumura M; Shimizu K; Yamamoto H; Mekata E; Tani T; Sato M
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):385-7. PubMed ID: 22421764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The future of loco-regional treatment for advanced gastric cancer].
    Nagahama T; Ando M; Ganno H; Ami K; Fukuda A; Maruyama M
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2012-4. PubMed ID: 19106507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.